Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
MERCK, SHARP & DOHME CORP. et al v. AUROBINDO PHARMA LTD. et al
Case Number:
1:13-cv-05442
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
January 28, 2014
Merck, Bristol-Myers Settle With Generics Co. Over HIV Drug
Merck Sharp & Dohme Corp. and Bristol-Myers Squibb Co. have settled a suit against Aurobindo Pharma Ltd. over allegations that Aurobindo tried to introduce a generic version of HIV medication Sustiva before the drug's patents expire, according to a Friday filing in New Jersey federal court.
-
September 13, 2013
Merck, BMS Target Aurobindo Over Generic HIV Drug
Merck Sharp & Dohme Corp. and Bristol-Myers Squibb Co. sued Aurobindo Pharma Ltd. in New Jersey federal court on Wednesday, alleging the Indian drugmaker is trying to introduce its own version of HIV treatment Sustiva before the drugs' patents expire.